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Rapid Identification of Small Binding Motifs
with High-Throughput Phage Display: Discovery
of Peptidic Antagonists of IGF-1 Function
tions is particularly demanding because their binding
surfaces often contain few distinguishing features [3],
and therefore large, structurally diverse libraries are re-
quired for identifying potent ligands.
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and Development for the optimization of loops within proteins [4] and for
the identification of novel ligands [2]. M13 lends itselfGenentech
1 DNA Way to this process because engineering the viral DNA can
lead to the fusion of peptides or proteins of interestSouth San Francisco, California 94080
at the surface-exposed termini of several of its coat
proteins. One can create naı¨ve libraries of phage having
many different molecules fused to the coat by randomiz-Summary
ing certain codons within the synthetic oligonucleotides
used to engineer the viral DNA. Once the phage libraryA panel of 22 naı¨ve peptide libraries was constructed in
a polyvalent phage display format and sorted against is enriched with active peptides by binding phage parti-
cles to immobilized target, DNA sequencing may beinsulin-like growth factor-1 (IGF-1). The libraries were
pooled to achieve a total diversity of 4.4  1011. After used to identify those coat-protein-fused molecules that
are ligands to the target because of the link betweenthree rounds of selection, the majority of the phage
clones bound specifically to IGF-1, with a disulfide- phenotype (displayed molecule) and genotype (viral DNA).
An important factor in the selection process is theconstrained CX9C scaffold dominating the selection.
Four monovalently displayed sub-libraries were de- choice of coat protein for library display. Display on
the major coat protein (protein-8, P8) gives polyvalentsigned on the basis of these conserved motifs. Sub-
library maturation in a monovalent format yielded an display, with as many as several hundred copies of the
coat fusion protein present on each phage particle. Thisantagonistic peptide that inhibited the interactions be-
tween IGF-1 and two cell-surface receptors and those has the advantage of providing an avidity component
to binding to the immobilized target and often facilitatesbetween IGF-1 and two soluble IGF binding proteins
with micromolar potency. NMR analysis revealed that the selection of ligands that would bind weakly as mono-
mers. As a caveat, the avidity may confound measure-the peptide is highly structured in the absence of IGF-1,
and peptides that preorganize the binding elements ment of the tightness of binding (for example, in a phage
enzyme-linked immunosorbant assay [ELISA], see be-were selected during the sorting.
low), and enrichment of certain library members may
not correlate directly with target affinity of the libraryIntroduction
monomer. Alternatively, the library members may be
displayed on a minor coat protein (protein-3, P3). OnlyExploration of the cellular machinery is leading to the
discovery of complex signaling pathways that are often a few copies of this protein are present in each phage
particle, and by suitable engineering, the display of li-initiated by an extracellular ligand binding to a cell sur-
face receptor [1]. By specifically targeting these interac- brary members can be limited to one per phage particle
[5]. The monomeric nature of this display lends itself totions, researchers have been able to manipulate cellular
events in an attempt to one day alleviate disease. Inevi- selection for tight binding (for example, if one uses more
stringent selection conditions) and for the quantitationtably, controlling signal transduction with the specificity
necessary for therapeutic utility requires understanding of library members’ affinity for the target in phage ELISA
assays.manifold protein-protein interactions at the molecular
level. Antibodies, peptides, and small molecules are Various scaffolds have been used in previous dis-
coveries of novel ligands from naı¨ve phage-peptide li-powerful tools for investigating protein-protein interac-
braries. Such scaffolds have included unconstrainedtions, but their discovery and development can be labor
sequences, conotoxin derivatives [6], and peptidesintensive and time consuming. Over the past decade,
structurally constrained through a combination of pairscombinatorial methods such as phage display have as-
of cysteine residues (potential disulfide bonds) or Gly-sumed a critical role in the discovery of molecules used
Pro motifs (potential reverse turns) [7–10]. Commonly,for elucidating key ligand-receptor relationships (re-
peptide-phage libraries have been generated by com-viewed in [2]). Even with the large libraries accessible via
bining pools of phage displaying similar scaffolds (e.g.,phage display, a recurrent problem is that, as theoretical
structurally constrained peptides kept separate from lin-library size grows (i.e., as the size of the displayed pep-
ear motifs), with each library being pursued indepen-tides increases and more positions have to be random-
dently (e.g., see [8]). Parallel manipulation of severalized), representation of a significant proportion of its
libraries increases the labor involved but has the advan-constituents in a real, physical library becomes essen-
tage that several scaffolds capable of binding may betially impossible. Perturbation of protein-protein interac-
obtained. The identification of multiple peptide classes
able to bind to a target is advantageous in that it allows3 Correspondence: deshayes@gene.com (K.D.) sidhu@gene.com
(S.S.S.) subsequent categorization on the basis of target affinity,
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target specificity, or ligand characteristics (size, struc- rapid evaluation of selection or optimization by phage-
ELISA methods; and (6) limited peptide synthesis onlyture, solubility). This may not be possible in an “all-
in-one” library because avidity effects or expression- after high-affinity ligands have been identified.
The target investigated in this report is insulin-likebiased phage growth during amplification in E. coli may
lead to the domination of the selection process by one growth factor (IGF-1), a 70 residue peptide hormone
that regulates both mitogenic and metabolic functions,or a limited number of clones (e.g., see [9]). Because of
the benefits of avidity, initial screening has routinely primarily via binding to the cell surface IGF-1 receptor
(IGFR), an 22 heterotetramer related to the insulin re-been done on P8 with many rounds of selection (3–6)
to yield a small number of independent clones. At this ceptor (IR) (reviewed in [11]). IGF-1 activity is tightly
regulated, with IGF-1 existing in vivo primarily bound topoint, peptide synthesis is used to make specific pep-
tides and test for activity. This can be an expensive and one of six soluble IGF binding proteins (IGFBPs) that
regulate IGF-1 biological availability and plasma half-time-consuming process, particularly if the initial ligands
are of low affinity. Only once this has been accomplished life by sequestering the hormone within high-affinity
complexes [12–16].are secondary phage libraries designed as P3 con-
structs to optimize the initial ligands. IGF-1 has a broad range of biological activities, and
maintaining proper levels of IGF-1 signaling is importantRecent modifications to the phage display technique
have led to significant gains in practically accessible for normal cellular function [17–19]. A significant chal-
lenge in developing therapeutics based upon IGF-1 issequence diversity [5]. These modifications include (1)
increasing the size of peptide libraries to more than 1010 understanding the interplay of the interactions that con-
trol IGF-1 signaling. Evidence for specific epitopes onmembers; (2) combining several libraries so that several
scaffolds can be investigated simultaneously; (3) mining IGF-1 for the different receptors has been obtained
through alanine scanning mutagenesis [20–22]. Addi-sequence data from early rounds of sorting to obtain
information with which to design a directed search of tional information about ligand binding to IGF-1 is found
in crystal structures of IGF-1 bound either to a fragmentsequences space; and (4) developing a protocol for the
accurate and rapid analysis of hundreds, or even thou- of IGFBP5 [23] or a detergent (deoxybigchaps) [24].
In this paper, we discuss the application of our refinedsands, of clones. Herein, we describe how we have
incorporated these improvements into our ligand dis- phage display technology to the discovery of peptide
antagonists of IGF-1. Such molecules would have con-covery process with the aim of decreasing the time,
effort, and cost of obtaining peptides that bind to a siderable utility in unraveling IGF-1 function, e.g., by
antagonizing its effects in cell-based assays. We de-particular target protein (Figure 1).
We originally cast a broad net in the naı¨ve polyvalent scribe the rapid progression from large naı¨ve libraries
to more focused libraries to active synthetic peptides.sort by sampling an extremely diverse collection of se-
quences and scaffolds for potential binding motifs. The Library design and information gathering and sorting
procedures are presented, along with in vivo potencyphage-displayed libraries were pooled and cycled
through rounds of binding selection with immobilized and NMR structural data. Finally, in order to elucidate
the mechanism by which the affinity maturation oc-target protein to select for members that bound specifi-
cally to the target. After a minimal number of selection curred, we compare the structural features of a potent
peptide obtained from monovalent maturation to that ofcycles, phage binding ELISAs were used to identify indi-
vidual clones that bound specifically to the target. The a low-affinity parent from the original naı¨ve sort.
sequences of binding peptides were then deduced from
the sequences of the cognate DNA encapsulated within
Resultsthe phage particles. Because an extremely diverse li-
brary pool had been subjected to a low-stringency se-
Naı¨ve Polyvalent Librarieslection process, we sought to obtain many positive
As part of the streamlined protocol used in the presentclones that could be grouped into families on the basis
study, we chose to minimize the amount of manual inter-of amino acid sequence similarity.
vention by using a single, combined library containingSecond-generation libraries were displayed in a
22 P8 polyvalently displayed peptide-phage librariesmonovalent format on P3 to enable stringent selection
(Table 1) with a combined diversity of 4.4  1011. Theseand evolution of high-affinity binders through a combi-
scaffolds included linear sequences, conotoxin deriva-nation of changes in backbone structure and/or inter-
tives [6], and peptides structurally constrained throughacting side chains. Furthermore, while peptides were
the inclusion of pairs of cysteine residues and Gly-Prodisplayed monovalently on phage, their affinities could
motifs. Multiple rounds of sorting are commonly em-be assayed directly [5], allowing us to continuously mon-
ployed to enrich the fraction of binding to nonbindingitor the selection process to identify high-affinity bind-
clones. However, “over sorting” may lead to dominationers. Once affinity had been optimized to a satisfactory
by preferentially expressed clones and a loss of se-level, peptide sequences were synthesized and sub-
quence diversity. Thus, we employed an ELISA-basedjected to detailed analysis of structure and function.
assay after every round of sorting to measure the pro-This approach has several advantages, including (1) time
portion of clones capable of binding IGF-1. In this way,saved because of sorting a single combined library; (2)
we maintained diversity among the selected sequencesreduced expression bias among the selectants because
by halting the selection process as soon as the fractionof limited rounds of sorting; (3) utilization of fast DNA
of binding to nonbinding clones reached a predeter-sequencing of many positive clones; (4) identification
and maturation of multiple scaffolds at one time; (5) mined level. The single-point ELISA for measuring IGF-1
Discovery of Peptidic Antagonists of IGF-1 Function
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Figure 1. Schematic Diagram for the Polyva-
lent Naı¨ve Selection and Monovalent Affinity
Maturation of Binding Motifs
binding uses anti-phage antibodies to detect phage analysis to that described below for the highly populated
CX9C scaffold.bound to immobilized IGF-1 (see Experimental Proce-
dures). This procedure is readily adapted to a high- The CX9C scaffold is most prevalent in the sequenced
clones, and we focus on this family for the remainderthroughput format; hence, this additional step in the
sorting protocol does not significantly increase the over- of our analysis. Alignment of the 15 sequences on the
basis of cysteine position reveals a number of conservedall time of the sorting process.
After three rounds of sorting, more than 90% of the residues within the X2CX9CX2 core. From this alignment,
the sequences fall into two related families (Table 2).picked clones were positive for IGF-1 binding. Nonselec-
tive binding was ruled out because these clones did Family 1 has a consensus of serine at position 6, leucine
at position 10, and methionine at position 14. Positionsnot bind to immobilized bovine serum albumin (BSA).
Ninety-six colonies selected at this point were se- 7, 9, and 11 show a preponderance of two or three
amino acid types, e.g., position 11 favors basic residuesquenced to identify the peptides responsible for IGF-1
binding. Gratifyingly, diversity was maintained at both whereas position 7 shows a clustering of small, hy-
drophobic groups. Family 2 exhibits a consensus ofthe sequence and the scaffold levels. Representatives
from six of the initial peptide sub-libraries were present aspartic acid at position 6, tyrosine at position 12, and
tryptophan at position 14.in the 28 unique clones (Table 2). Within the most popu-
lous scaffold (CX9C), there was considerable sequence
diversity. These data suggest that sequence information Monovalent Library Design and Selection
Usually, once a few unique clones have been identifiedfrom a single 96-well plate is capable of identifying pre-
ferred scaffolds and that, for at least some of these from phage naı¨ve peptide libraries, peptides would be
synthesized, and further biochemical characterizationscaffolds, a variety of sequences capable of binding
are observed (see Experimental Procedures). Given the would be performed. Information gleaned from these
studies would form the basis of second-generationefficiency of microtiter plate-based DNA sequencing,
this amount of sequence data is readily obtained and phage library design that would be used in affinity matu-
ration of the initial ligand. In the present streamlinedthus does not increase the overall time required to obtain
ligands to a given target. We note that sequencing of analysis of IGF-1 binding peptides, we chose not to
perform costly and time-consuming peptide synthesisadditional colonies may identify additional sequence in-
formation for other scaffolds and thereby permit a similar at this stage. Instead, we were able to use the sequence
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Table 2. IGF-1 Binding Peptides Selected from Naı¨ve LibrariesTable 1. Naı¨ve Polyvalent Peptide-Phage Libraries Sorted for
Binding to IGF-1
Scaffoldb Peptide Sequencea
Librarya Designb Diversityc ( 1010)
X20 ASQTPWPYSILFGEWWNAGF
EAGAESRGWLQARCGELLGV1 X8 2.6
2 X20 1.2 HWDWTGGYWWIGREPWKEAA
RLNAEGLRMGWGYMVWHWLS3 CX6CX6CCX3CX6Cd 1.6
4 CCX3CX6Cd 1.7
CXCX7CX3CX6 CECGKVSSRGCEKLCWLVSYM5 CCX5CX4CX4CCd 1.6
6 CXCX7CX3CX6d 1.5 CX6C GAWAWLCEQREEWCGWMLGT
7 X4CX2GPX4CX4 2.0 YDWVEACQKWPVLCMDSTMY
8 CX2GPX4C 2.5
9 X7CX4CX7 2.5 CX7 GIREELCDKGLHKMCFREVR
10 X7CX5CX6 1.4
CX8C DAMDCVVGPEWRKCFLEGG11 X6CX6CX6 2.5
SGTACRWGPSWLLCSLASS12 X6CX7CX5 2.1
GEGPECDLRQWGNLCSHWET13 X5CX8CX5 1.9
LSSEECWEALKWQGCLMSER14 X5CX9CX4 2.0
SFCEFNDWWPTCLV15 X4CX10CX4 2.5
16 X2CX4CX2 2.1 CX9Cc VKDECLMSVEALKNCMGLVS
17 X2CX5CX2 2.2 IDCLDSVEALKQCMY
18 X2CX6CX2 1.5 VESECLLSLPNLRRCMMDRL
19 X2CX7CX2 2.1 Family 1 HPDKCFADVRALQECMESVR
20 X2CX8CX2 2.1 VEEKCYESITALRHCMQAMQ
21 X2CX9CX2 2.2 QIPAGCYESVQSLLECVQSA
22 X2CX10CX2 2.4 VMDQCFESYAEMRKCMLDGS
Total 44.2 EVARCVVDAGGTWYCWAEMA
IECWQDLQGTRLCWEa Libraries were displayed on gene-8, under the control of the Ptac
GESTCVTDLERVEYCWDEKSpromoter.
Family 2 STYSCIRDMGWAVYCWETTLb Fixed residues are denoted by the single-letter amino acid code,
GVETCYSDAMNTQYCWTTELand “X” denotes a randomized position where an NNK degenerate
REVKCMKDLSGHEYCWAEPRDNA codon encodes all 20 natural amino acids.
GEAAECAYDSLGMAYCYAKEc For sorting, the libraries were pooled to achieve a total diversity
TAGIECAYDKHLDQYCWWKEof 4.4  1011.
d Conotoxin derivatives. The libraries shown in Table 1 were pooled and cycled through three
rounds of selection for IGF-1 binding.
a Underlined residues were fixed as cysteines in the library construc-
tions.
similarity information obtained from the initial polyvalent b Sequences were grouped into scaffold classes on the basis of
selection to guide the design of second-generation cysteine spacing.
c Most sequences were from the CX9C scaffold, and these could bephage libraries. In order to keep the theoretical diversity
divided into two families on the basis of sequence conservationwithin the limits of the library size and still fully explore
(shown in bold text).the sequence space suggested by the similarity align-
ment, we constructed two libraries for each family with
a combination of “hard” randomization (allowing for the
expression of any amino acid), and “tailored” random- second cysteine displayed conservation as large hy-
drophobes (tyrosine and tryptophan), and positions 4ization (allowing for the expression of only a particular
subset of amino acids) (Table 3). and 7 had a propensity toward small hydrophobic resi-
dues (Table 3). The tyrosine and tryptophan were heldDifferent tailored codons were used at the same posi-
tions within each sub-library, allowing sequence vari- constant, and other positions took advantage of tailored
codons encoding either charged residues, small resi-ability while limiting overall library size. For example, in
position two of family 1, library F1-A uses the VVK codon, dues, or nonaromatic hydrophobic residues. The NNK
codon was used more frequently, giving larger theoreti-whereas F1-B uses the GAS codon (Table 3). Use of the
VVK codon excludes uncharged hydrophobic residues cal diversities for the family 2 sub-libraries. However,
the theoretical diversity was overrepresented in eachin this position, and use of the GAS codon takes advan-
tage of residue conservation by allowing incorporation case, with libraries containing from 2.0 1010–2.6 1010
unique members (see Table 3). For binding selection,of only the negatively charged aspartate and glutamate
residues. For both F1 libraries, the first and last residues the A and B sub-libraries were combined for each family;
families 1 and 2 were sorted separately.were hard randomized with the NNK codon, which en-
codes all twenty natural amino acids. In the design of Peptides were displayed at the N terminus of human
growth hormone (hGH) fused to the C-terminal domainboth the F1 and F2 libraries, the disulfide constraint was
left intact. Most of the residues within the loop between of the gene-3 minor coat protein. This ensures that the
peptides are displayed in a stringent monovalent formatthe cysteines showed some level of conservation,
allowing us to design library F1-A with more unique because hGH is displayed at low levels on M13 phage
[4]. An additional benefit of this display format is that itcodons and library F1-B with more degenerate codons.
A smaller hydrophobic motif was recognized within the allows one to test for monovalent display. After a sort
against IGF-1 for primary binding function, a secondfamily 2 sequences (Table 2). The residues flanking the
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Table 3. Second-Generation Library Designs for Affinity Maturation of IGF-1 Binding Peptides
aTo ensure monovalent display, we linked the libraries to hGH, which in turn was fused to the C-terminal domain of P3.
bEach library encoded peptides containing 15 residues. Tailored DNA codons were used to vary the level of amino acid diversity at each of
the 15 positions within each library. DNA codons are shown in bold text, and the encoded amino acids are shown below in italics. Fixed,
moderately randomized, and hard-randomized positions are shown in black, green and red, respectively.
cFor each library design, the theoretical diversity (the number of different amino acid combinations encoded by the degenerate codons) was
exceeded by the actual diversity of the constructed library.
sort against an anti-hGH antibody is conducted to en- allows the affinity of any hGH-peptide fusion to be deter-
mined for any protein target without the need to developsure that only peptides displayed on the N terminus of
hGH have been selected. After four rounds of panning, new reagents. Although the phage competition results
are not a direct measure of the binding constant becauseELISA analysis of randomly selected clones showed the
presence of selectants that bound to IGF-1 and anti- the exact display level of each peptide on phage is not
known, the phage ELISA method provides rapid accesshGH antibody, with the majority of the clones showing
a strong response. None of the clones bound to BSA, to the relative affinities of a large number of sequences.
Eight selectants from the F1 library selection and tenindicating we had generated a pool of monovalent pep-
tides that bound selectively to IGF-1. selectants from the F2 library selection were analyzed
by competition phage ELISA, giving IC50 values rangingAn additional selection round was performed under
more stringent conditions to remove the weaker binding from low micromolar to submicromolar (Table 4). The
three highest affinity sequences from the F1 library se-clones from the pool. Phage were bound to a low con-
centration (1 nM) of biotinylated IGF-1 in solution; rapid lection and the two most potent peptides from the F2
library selection were chosen for structure-functioncapture with streptavidin-coated magnetic followed.
Using a low concentration of target protein increased analysis as synthetic peptides. As a test of the methodol-
ogy, we also synthesized two peptides based on se-the selection stringency to allow capture of only the
highest affinity phage clones. After this final round of quences obtained in the naı¨ve sort (Table 4).
sorting, all the clones tested in the ELISA assay were
positive for binding to both IGF-1 and anti-hGH an- Functional Analysis of Synthetic Peptides
tibody. Seven peptides were synthesized by standard Fmoc
chemistry, corresponding to the second-generation
phage-derived sequences and two parent sequencesAssessment of Binding Affinity
with Competition ELISA from the naı¨ve selection (Table 4), with an additional
glycine residue from the C-terminal linker to more pre-The low level of peptide display with the monovalent
hGH-fusion format allows the assessment of peptide cisely represent the peptide as displayed on phage.
As synthetic peptides, the two families demonstratedaffinity via a competition analysis while the peptide is
still attached to the phage particle [5]. This procedure distinct physical and functional characteristics. The
peptides from Family 2 were poorly soluble; they under-gives information about potency and allows us to rapidly
identify potential leads for synthesis and further charac- went aggregation in aqueous solution and therefore
yielded unreliable results. In contrast, the peptides fromterization. The clones were examined via an ELISA in
which soluble IGF-1 inhibited phage-displayed peptides Family 1 were highly soluble; thus, they could be readily
assayed and showed interesting activities (Table 5). Thisfrom binding to immobilized IGF-1 (Experimental Proce-
dures); anti-M13 phage antibody HRP conjugate is used outcome highlights the fact that the properties of pep-
tides displayed on phage can differ significantly fromto detect the phage bound to immobilized IGF-1, and an
IC50 value is determined. Importantly, this assay format those of the same peptides free in solution. This obser-
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albeit with lower potency (see Table 5). The parent pep-Table 4. IC50 Values for the Interaction between IGF-1 and
Phage-Displayed Peptides tide, IGF-F1-parent, did not block the IGF-1 interaction
with the IGFBPs within the detection limits of the experi-Peptideb Sequence IC50 (M)a
ment (IC50  750 M).
F1-Parent DECLMSVEALKNCMG – A cell-based in vitro binding assay was used to test
F1-1c RNCFESVAALRRCMY 0.1  0.02
for peptide antagonism of the interaction between 125I-F1-2c MDCLASVEALKWCMY 0.1  0.07
IGF-I and the IGFR on cells in culture. The four peptidesF1-3c FECLTSVEALRGCMY 0.3  0.08
from family 1 were preincubated with 1 nM 125I-IGF-1F1-4 FGCYESVAALRTCMY 0.3  0.1
F1-5 HPCLESVGALKACMY 0.4  0.06 prior to incubaton with MCF-7 cells that express IGFR.
F1-6 HDCFASVEALRRCMY 0.5  0.13 The cells were subsequently washed to remove un-
F1-7 SDCFGSVEALKMCMY 0.7  0.4 bound 125I-IGF-1, and the residual radioactivity was mea-
F1-8 SDCFESVEALRACMY 1.0  0.7
sured after cell lysis to test the extent to which theF2-parent ARCVVDAGGTWYCWA –
peptides antagonized IGF-1 binding to IGFR. All F1 pep-F2-1c ARCVVDAGGTWYCWA 0.5  0.2
tides, except for IGF-F1-parent, showed inhibition of 125I-F2-2c LGCASDLAGFWYCWA 0.3  0.07
F2-3 WRCVDDLGGFQYCWA 1.0  0.6 IGF-1 binding to IGFR on MCF-7 cells (Table 5). Finally, a
F2-4 ASCVADAGGGGYCWD 1.0  0.7 cell-based in vitro kinase receptor activation (KIRA)
F2-5 GGCASDLAGFRYCWE 1.0  0.4 assay was used to test the effects of the peptides on
F2-6 VTCAADALGFLYCWE 2.0  1.0
cultured cells transfected with functional insulin recep-F2-7 LRCAEDLGGYFYCWA 1.4  0.4
tor (IR). In this assay, increased phosphorylation of re-F2-8 YRCATDLAGFSYCWA 4  5
ceptors is seen after cells are stimulated with IGF-1,F2-9 ARCARDAGGFYYCWA 1.0  0.7
F2-10 WRCAQDAGGWTYCWA 1.0  0.4 which binds and activates the IR with an EC50 of about
50 nM (data not shown). The results show that all thea The IC50 values are the concentrations of IGF-1 that blocked 50%
synthesized peptides inhibit receptor activation (Tableof phage-displayed peptide binding to immobilized IGF-1 in a phage
ELISA. 5). Interestingly, the IC50 values for the three matured
b The monovalent peptide-phage were from either library F1 or F2 peptides are equally potent across all four assays,
(Table 3) and were selected for high-affinity binding to IGF-1. whereas IGF-F1-parent shows weak activity only in the
c Sequences chosen for chemical synthesis and detailed functional insulin receptor KIRA assay.
analysis.
Structural Analysis of Synthetic Peptides
NMR chemical shift and 3JHN-H data for IGF-F1-1 devi-vation also emphasizes the importance of not per-
forming excessive rounds of selection; if F2 family mem- ated from random coil values (see Supplemental Mate-
rial), suggesting that the peptide has a preferred confor-bers had dominated in subsequent rounds of selection,
then useful (i.e., soluble) peptide ligands for IGF-1 may mation in solution. In particular, the 3JHN-H values for a
number of residues (Ala8, Ala9, Leu10, Arg11, andnot have been discovered.
The binding of IGF-F1-1 to IGF-1 was measured by Cys13) were less than 6.0 Hz, suggesting a helical con-
formation in this region of the peptide. The ensembleusing synthesized peptide to compete with IGF-F1-1
displayed on phage for binding to IGF-1 coated on a and minimized mean structure determined on the basis
of NMR-derived experimental restraints are shown inplate; the resulting IC50 was 7.2  3.4 M (data not
shown). More functionally relevant assays were carried Figure 2.
Analysis via the Kabsch and Sander secondary struc-out with four IGF-1 binding partners to measure the
antagonism of IGF-1 binding by the synthetic F1 pep- ture algorithm within PROCHECK [25] suggested that
IGF-F1-1 contains an  helix from Val7 to Met14; Ser6tides. For IGFBP-1 and IGFBP-3, we incubated each
peptide with IGF-1 linked to P3 on phage and measured and Tyr15 are extensions of the main helix. Hydrogen
bonding interactions consistent with the helical designa-residual IGF-phage binding to each of the IGFBPs in a
plate-based ELISA. Peptide IGF-F1-1, the highest affin- tion are observed in most of the structures within the
ensemble. Cys3 and Phe4 adopt a reverse turn orienta-ity peptide when displayed on phage (Table 4), was
also the most potent antagonist of each of the binding tion (distorted Type I) in slightly more than half of the
members of the ensemble. Residues Arg1, Asn2, andproteins (Table 5). Peptides IGF-F1-2 and IGF-F1-3 also
blocked the binding of IGF-1 to IGFBP-1 and IGFBP-3, Gly16 are not well defined by the NMR restraints and
Table 5. IC50 Values for IGF-1 Binding Synthetic Peptides
IC50 (M)a
Peptide Sequence IGFBP-1 IGFBP-3 IGFR IR
F1-parent DECLMSVEALKNCMGG-NH2 750 750 750 180
F1-1 RNCFESFVAALRRCMYG-NH2 1.4 2.9 5.1 5.5
F1-2 MDCLASVEALKWCMYG-NH2 16 9.2 15 33
F1-3 FECLTSVEALRGCMYG-NH2 12 13 46 66
a The IC50 values are the concentrations of peptide that blocked 50% of the signal in assays designed to measure the interaction between
IGF-1 and each of its ligands. The IGFBP values were from competitive ELISAs, the IGFR values were from MCF7 cell-based assays, and the
IR values were from a KIRA assay (see Experimental Procedures for assay details).
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Figure 3. Comparison of Chemical Shifts for IGF-F1-1 and IGF-F1-
Parent
(A) Secondary H chemical shifts (values for peptide  random-coil
values) are plotted with solid and gray bars for IGF-F1-1 and IGF-
F1-parent, respectively. Random-coil values were taken from [35].
(B) Secondary C chemical shifts (values for peptide  random-coil
values) are plotted with solid and gray bars for IGF-F1-1 and IGF-
F1-parent, respectively.
Figure 2. Three-Dimensional Structure of IGF-F1-1 in Solution may be less highly populated and therefore less well
(A) Ensemble of 20 IGF-F1-1 structures superimposed by using the defined and more dynamic in nature. Given this, a struc-
N, C, and C atoms of residues Phe4-Tyr15. The side chains of the
ture was not determined for IGF-F1-parent.hydrophobic residues on one face of the helix are shown.
(B) Minimized mean structure of IGF-F1-1 showing the heavy atoms
of all side chains except Arg1 and Asn2.
Discussion
In the present work, we have described a modified pro-may be more flexible in solution than the other residues.
There are extensive hydrophobic contacts between the tocol for the identification of novel peptide ligands by
using phage-displayed libraries. The aim of these modi-side chains of Phe4, Val7, Leu10, Met14, and Tyr15.
These residues also pack on top of the disulfide bond fications was to decrease the time and expense of identi-
fying ligands and also to identify a number of classes(residues Cys3 and Cys13). Presumably, the nonbonded
interactions along this face of the helix help to stabilize of potential ligands for further optimization and charac-
terization. A key component was the use of generic (i.e.,the folded conformation of the peptide.
IGF-F1-parent, the precursor to IGF-F1-1, was also target-independent) procedures and analytical tools
that are fast and highly automatable; such tools includedstudied by NMR (Supplemental Material). In the region
of the helix observed in IGF-F1-1, the H and C chemical plate-based ELISA readouts and DNA sequencing. Initial
searching was performed with a single large multiple-shifts of IGF-F1-parent are systematically shifted from
random coil values in a direction consistent with a helix scaffold library by the use of polyvalent display to boost
target binding via avidity. Single-point ELISA tests werealso being present. However, the shifts are not as ex-
treme as in IGF-F1-1 (Figure 3). The values of 3JHN-H in used to assess the binding competency of clones and
to prevent loss of diversity through over-sorting. Oncethe helix are also smaller in IGF-F1-parent (mean for
Val7-Met14  6.4 Hz) than in IGF-F1-1 (mean for Val7- the majority of the clones bound to target, a relatively
large number of binding clones were sequenced, andMet14  5.5 Hz; see Supplementary Material). In addi-
tion, very few of the medium-range ROEs present in these data were used to design focused second-genera-
tion libraries that could be exhaustively sampled for theIGF-F1-1 are observed in the parent peptide. These data
all suggest that although IGF-F1-parent may adopt a highest affinity ligands. The use of monovalent display
was critical for this step to allow more stringent selectionstructure similar to that of IGF-F1-1, this conformation
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of ligands whose affinity could be measured directly by Leu10, and Met14) identified in the initial selection (Table
2). Although these residues are identical or of similarphage ELISA, unimpeded by avidity effects. Expensive
and time-consuming peptide synthesis was not per- character in the naı¨ve selected peptide IGF-F1-parent,
the affinity for IGF-1 is at least an order of magnitudeformed until after the final affinity maturation step.
Using this optimized protocol, we sought to identify less than that of the affinity-matured peptide IGF-F1-1,
as judged from the IGFBP1 and IGFBP3 competitionligands to the growth factor IGF-1. The initial naı¨ve selec-
tion yielded peptides from six distinct scaffolds, with binding studies (Table 5). The working model we have
developed for the evolution process is that approximateone scaffold, CX9C, dominating the sequenced clones.
Of the two families of related CX9C peptides derived binding solutions are found within incomplete, but highly
diverse, polyvalent libraries that allow us to identify bind-from the sequences, the family F1 contained a more
highly conserved motif (Table 3). Sequence alignments ing motifs and, therefore, to design directed libraries
with complete coverage of relevant sequence space.were made between the five F1 and F2 peptides that
were synthesized and all human IGFBPs, IGF-R1, IGF- The directed libraries contain peptides with the binding
epitope displayed on a more highly structured scaffold,R2, and IR. In no case was an identity of more than 30%
observed, and in nearly all cases gaps were required so that these peptides bind IGF-1 with higher affinity and
are selected preferentially. Although this model agreesto obtain any alignment identity greater than 15% (our
unpublished data). Thus, the selection sequences are with our results for IGF-1 ligands, identification and opti-
mization of ligands to other targets will be required tonovel epitopes for binding IGF-1 and are not simply
linear fragments of known IGF binding proteins. test if it is generally applicable. If our model is correct,
the discovery of a tight binding peptide by this method-Synthetic peptides derived from affinity maturation of
F1 bind to IGF-1 with good potency and have a well- ology requires the presence of a highly conserved bind-
ing core in the original selection. The probability of thisdefined solution structure (Table 5 and Figure 2). The
other family, F2, is based on a less well-defined consen- occurring is dependent on the properties of target,
choice of libraries, and completeness with which thesus sequence (Table 2); synthetic peptides from this
family had a tendency to aggregate or have limited solu- libraries are sampled. In this case, by using the maxi-
mum diversity available to us, we found consensus mo-bility, making characterization of their structure or IGF-1
affinity problematic. The affinity-matured F2 sequences tifs that led to potent binders by sequencing fewer than
100 clones.that could be assessed by phage ELISA were found to
be less potent than the F1 sequences (Table 4). The Previous mutagenesis studies have identified distinct
epitopes on IGF-1 that interact with binding proteinslower level of consensus in naı¨ve F2 sequences sug-
gests that we might have started with a sub-optimal and receptors [20, 21]. These data suggest that the
IGFBPs and receptors bind to different and distinct re-binding epitope that could not evolve into a useful high-
affinity ligand. The generality of the correlation between gions of the growth factor. However, binding to IGFBP-1
or other binding proteins does inhibit receptor signalinghigh consensus in naı¨ve sorts and higher potency in
the final optimized affinity remains to be seen but will by IGF-1 [17]. This implies that IGFBP binding partially
blocks the receptor binding site or induces a conforma-become clearer as we gain more experience with using
this modified procedure for ligand discovery. tional change in IGF-1 that influences the display of the
receptor epitope; the latter seems reasonable given theAlthough selection was based only on the ability of
peptide-phage to bind to IGF-1, the sequence of IGF- highly dynamic nature of IGF-1 in solution [29]. Interest-
ingly, IGF-F1-1 antagonizes IGF-1 binding to IGFBPsF1-1 also folds into a stable, compact structure. We are
aware of two examples [7, 26] in which the conformation and cell-surface receptors with similar potency. As with
the mutagenesis results, this result may be rationalizedobserved for a phage-derived peptide in solution is simi-
lar to that present when the peptide is bound to the in two ways (direct steric blocking or an allosteric pertur-
bation of the binding site), and both may be occurring.target protein. Selection of a peptide that has a stable
fold in solution and does not change significantly upon Structural characterization of IGF-1 in complex with IGF-
F1-1 is currently underway. These experiments will re-binding to its target provides an energetic benefit to
binding because the association will not lead to a loss veal the molecular details of how the phage-derived
peptide recognizes IGF-1. Moreover, by making com-of conformational entropy. Accordingly, structured pep-
tides derived from phage [7, 9, 26–28] retain their native parisons to previous structures of IGF-1 [23, 24], and to
conformations when they are bound to the target pro- mutagenesis data [20–22], we hope to shed light on how
tein, suggesting that the structure of IGF-F1-1 bound to IGF-1 activity is controlled by binding to peptides or
IGF-1 is preserved. Interestingly, the fold observed in binding proteins.
IGF-F1-1 (N-terminal loop, C-terminal helix) has been
observed in a number of other phage-selected protein
Significanceligands, suggesting an inherent stability of this motif [7,
9, 26–28]. Moreover hydrophobic residues on one face
In this report we described methodology that maxi-of the helix provide important contacts for binding to
mizes the diversity that can be sampled by the use ofthe target protein in several of these examples [7, 26–28].
peptide-phage libraries to rapidly identify and assessOn the basis of these prior findings, we hypothesize that
peptide ligands for any target. The major points arethe hydrophobic patch depicted in Figure 2 probably
(1) sorting a large (1011) library of naı¨ve peptides forrepresents the surface that IGF-F1-1 uses to bind to
binding to a target protein, as well as sequencing aIGF-I. An important observation is that the hydrophobic
patch is formed by the consensus residues (Phe4, Val7, moderate number of clones, can yield a recognizable
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second-generation peptide libraries were constructed as shown inmotif that is responsible for binding; (2) the naı¨ve poly-
Table 3.valent sort identified the residues necessary for form-
Phage from the second-generation libraries were cycled throughing the binding surface, and the subsequent evolution
four rounds of binding selections as described above. For rounds
of directed sub-libraries enabled us to access all the one and three, immobilized IGF-1 was used as the capture target,
sequences that present this motif; (3) peptides that with 0.2% BSA in the blocking buffer and the phage cocktail. Rounds
two and four used anti-hGH monoclonal antibody 3F6.B1.4B1 [5]presented a more structured binding interface were
as the capture target, with 0.2% casein in the blocking buffer andselected in the second-generation monovalent sort;
the phage cocktail. The clones were assayed for binding to IGF-(4) the increase in potency is probably due to preorga-
F1-1, BSA, and anti-hGH monoclonal antibody 3F6.B1.4B1. A fifthnization of the binding interface; (5) the most potent
round of selection was conducted in which the harvested phage
peptide derived from monovalent selection, IGF-F1-1, pool was incubated with 1.0 nM biotinylated IGF-1 (bio-IGF) in BSA/
antagonizes the interaction of IGF-1 with the IGFBPs Tween buffer for 2 hr. The phage/bio-IGF solution was added to
streptavidin-linked magnetic beads (Promega) (previously blockedand cell-surface receptors with low micromolar IC50
with BSA). After 30 min, the magnetic beads were washed with PBSvalues; (6) all three peptides tested from the monova-
and 0.05% Tween 20 to remove unbound phage. The remaininglent sort showed similar activity profiles against all of
phage were eluted with 0.1 M HCl and neutralized by the additionthe IGF-1 ligands tested; and (7) sequences derived
of 1/6 volume of 1.0 M Tris (pH 8.0). Individual clones from round
from the naı¨ve sort could show different activities and 5 were analyzed by single-point phage ELISAs (see below). Positive
selectivities and suggest additional binding motifs. monovalent phage clones were identified as those that bound to
both IGF-1 and anti-hGH antibody but not to BSA. Positive clones
were subjected to DNA sequence analysis (see below).Experimental Procedures
Construction of Polyvalent Naı¨ve Peptide-Phage Libraries Single-Point Phage ELISA
Libraries were constructed by previously described methods [5], To facilitate the rapid analysis of hundreds of unique phage clones,
with a phagemid vector containing an IPTG-inducible Ptac promoter we used a 96-well format for phage growth and ELISAs. Individual
driving the expression of open-reading frames encoding fusion pro- E. coli XL1-blue colonies harboring phagemids were picked into 500
teins of the following form: the StII secretion signal (MKKNIAFLLAS l of growth medium (2YT supplemented with 50 g/ml carbenicillin
MFVFSIATNAYA), followed by a random peptide, followed by a linker and 1010 pfu/ml VCS-M13 helper phage) in 1.2 ml culture tubes in a
(GGGSGGG), followed by the M13 gene-8 major coat protein (AEG 96-well format. After overnight growth, the tube racks were centri-
DDPAKAAFNSLQASATEYIGYAWAMVVVIVGATIGIKLFKKFTSKAS). fuged for 10 min at 2.5k rpm in a Sigma 3–12 centrifuge equipped
Twenty-two different peptide libraries were constructed (Table 1), with an Nr.11222 rotor. The phage supernatants (300 l) were trans-
and peptide-phage displaying the libraries were purified by precipi- ferred to 96-well plates and used directly in single-point phage
tation with PEG/NaCl, as described previously [5], and stored ELISAs.
at 70	C. For phage ELISAs, 96-well maxisorp immunoplates (NUNC) were
coated with 100 l of 5 g/ml capture target protein, blocked with
BSA, and washed (as described above). Phage supernatants (50 l)Selection of IGF-1 Binding Peptides from Naı¨ve
were added to individual wells and incubated for 1 hr with shakingPeptide-Phage Libraries
at room temperature. The plates were washed eight times with PBSIGF-1 was obtained as described previously [24]. Immunosorbant
and 0.05% Tween 20, incubated with 50 l of 1:10,000 horse radishplates (Nunc Maxisorp) were coated with 5 g/ml of IGF-I in 50 mM
peroxidase/anti-M13 antibody conjugate (Pharmacia) in BSA/Tweensodium carbonate buffer (pH 9.6) for 1 hr at room temperature,
buffer for 30 min, and then washed eight times with PBS and 0.05%followed by blocking for 1 hr with 0.2% BSA in phosphate-buffered
Tween 20 and two times with PBS. Plates were developed with asaline (PBS). The plates were washed with PBS and 0.05% Tween 20.
tetramethylbenzidine substrate (TMB, Kirkegaard and Perry, Gaith-Phage from 22 naı¨ve peptide-phage libraries (Table 1) were pooled
ersburg, MD), quenched with 1.0 M H3PO4 (50 l), and read spectro-and cycled through three rounds of binding selection on immunosor-
photometrically at 450 nm.bant plates coated with IGF-1. In the first round, 4.8 ml of phage
cocktail (1013 phage/ml in PBS, 0.05% Tween 20, and 0.2% BSA
[BSA/Tween buffer]) were added to 48 coated wells (100 l/well). DNA Sequencing
After 2 hr incubation at room temperature with shaking, the plate DNA sequencing was performed in a 96-well format. Culture super-
was washed with PBS and 0.05% Tween 20 to remove unbound natants containing phage particles (see above) were heat sterilized
phage. Bound phage were eluted with 0.2 M glycine (pH 2.0) (100 at 60	C for 1 hr and then used as the template (2 l) for a PCR that
l/well), and the phage eluant was neutralized by the addition of amplified a 300 base pair fragment surrounding the peptide library
1/6 volume of 1.0 M Tris (pH 8.0). The eluted phage were amplified sequence. Standard PCR conditions were used, with Taq polymer-
overnight by propagation in E. coli XL1-blue cells (Stratagene) with ase (1.25 units in a 25 l reaction, Applied Biosystems) as the ampli-
M13-VCS helper phage (Stratagene) and harvested by precipitation fying enzyme. Bipartite PCR primers were used to simultaneously
with PEG/NaCl as described previously [5]. The selection procedure amplify the DNA and to add M13(–21) and M13R universal sequenc-
for round three was identical to that for round one, whereas round ing primers to the 5
 and 3
 ends of the fragment, respectively. To
two differed only in the use of 0.2% casein in place of BSA in both degrade excess primers and nucleotides, we treated the PCR (5 l)
the blocking buffer and the phage cocktail. Individual phage clones with shrimp alkaline phosphatase (1 unit) and exonuclease-1 (10
at each round were analyzed for specific binding to IGF-1 with units) (USB) for 15 min at 37	C and 15 min at 80	C. The treated
single-point phage ELISAs (see below). Positive clones, those which PCR was used as the template in Big-Dye terminator sequencing
bound to IGF-1 but not BSA, were subjected to DNA sequence reactions (with either the M13(–21) or M13R universal sequencing
analysis (see below). primer). The sequencing reactions were analyzed on an ABI Prism
3700 DNA analyzer equipped with a 96-capillary array.
Second-Generation Affinity Maturation of IGF-1
Binding Peptides Affinity Measurement by Competitive Phage ELISA
A modified phage ELISA was used to estimate the binding affinitiesSecond generation libraries were constructed by previously de-
scribed methods [5], with a phagemid (phGHam-g3) [4] containing of selected second-generation IGF-1 binding peptides from above.
Phage ELISAs were carried out on plates coated with IGF-1, asan alkaline phosphotase promoter (PphoA) driving the expression
of fusion proteins of the following form: StII secretion signal, fol- described above. Peptide-displaying phage were serially diluted,
and binding was measured to determine a phage concentrationlowed by the second-generation peptide library, followed by the
linker sequence, followed by human growth hormone, followed by giving 50% of the signal at saturation.
A fixed, subsaturating concentration of peptide-phage was mixedthe C-terminal domain of the M13 gene-3 minor coat protein. Four
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with serial dilutions of IGF-1, incubated for 1.0 hr, and then trans- Structure Determination of IGF-F1-1 by NMR
1H NMR data were collected in H2O (with 10% v/v 2H2O) or 2H2Oferred to assay plates coated with IGF-1. After 30 min of incubation,
the plates were washed and developed, as described above. The solution at 30	C (pH 5.1) and 5.0 mM concentration. In addition to
one-dimensional spectra, two-dimensional double-quantum-fil-binding affinities of the peptides for IGF-1 were determined as IC50
values (Kaleidagraph) defined as the concentration of IGF-1 that tered correlation spectra (2QF-COSY), total correlation spectra
(TOCSY; tm  90 ms), and rotating-frame Overhauser effect spectrablocked 50% of the peptide-phage binding to the immobilized IGF-1.
An ELISA format was also used to measure the binding of synthetic (ROESY; tm  150 ms) were collected [9, 32]. After lyophilization and
dissolution of the peptide in 2H2O, a 2D ROESY spectrum and a COSYpeptide to IGF-1. Phage displaying IGF-F1-1 on P3 (no hGH) were
bound to a plate coated with IGF-1. Serial dilutions of synthetic spectrum with a 35	 mixing pulse [32] were acquired. Complete 1H
resonance assignments were obtained from these data by standardpeptide were used to determine the concentration at which 50% of
the phage were displaced. methods [33] and are listed in the Supplemental Material. Natural
abundance 13C HMQC and 13C-HMQC-TOCSY spectra were also
collected to facilitate assignment of the 13C resonances [32]. Dis-Peptide Synthesis
tance restraints were generated from H2O and D2O ROESY spectra,Peptides were synthesized by either manual or automated (Milligen
and dihedral angle restraints were derived from 3JHN-H or 3JH-H9050) solid-phase synthesis at 0.2 mM scale on PEG-polystirene resin
measured in H2O 2QF-COSY or D2O COSY-35 spectra, respectively,via Fmoc chemistry. Purification was as previously described [26].
processed to high digital resolution in F2 [32]. Additional φ and 
restraints were generated from the H, C, and C chemical shifts
Inhibition of IGF-I Binding to IGFBPs with the program TALOS [34]. Restraints were set to the value deter-
E. coli XL1-Blue cells harboring the phagemid pIGF-g3 were used mined from TALOS  the larger of either twice the TALOS standard
to produce phage particles displaying human IGF-1, as described deviation or 40	. Hydrogen bond restraints were not employed at
previously [22]. For each IGF-1 binding synthetic peptide, competi- any stage of the calculation process. The ROESY coupling constant
tive phage ELISAs were performed to determine IC50 values, defined and chemical shift data were used to generate 91 distance and
as the concentration of synthetic peptide that blocked 50% of the 26 dihedral angle restraints that were used as input to structure
IGF-1-phage binding to immobilized IGFBP-1 or IGFBP-3. The pro- calculations. One hundred initial structures were calculated with the
cedures were identical to those in section 5.6, except that plates hybrid distance geometry/simulated annealing program DGII [35];
were coated with IGFBP-1 or IGFBP-3, and subsaturating concen- 80 of these were further refined by restrained molecular dynamics
trations of IGF-1-phage were preincubated with serial dilutions of with the AMBER all-atom force field implemented in DISCOVER as
synthetic peptides. described previously [36]. Twenty conformations of lowest restraint
violation energy were chosen to represent the solution conforma-
tion. Mean coordinates generated from this ensemble were energyInhibition of IGF-1-Induced Activation of the Insulin Receptor
A kinase receptor activation (KIRA) assay was developed to measure minimized under the influence of the experimental restraints to pro-
duce a minimized mean structure. Restraint numbers and structuralthe phosphorylation of the human insulin receptor (hIR) in response
to exogenous IGF-1. The methods were modified from those of a statistics for the ensemble and minimized mean structure are pre-
sented in the Supplemental Material. Random-coil 13C chemicalpreviously described KIRA assay [30]. Chinese hamster ovary cells
transfected with hIR (TRY-IR 5.3 cells) were grown overnight at 37	C shifts for IGF-F1-1 and IGF-F1-parent were determined from values
tabulated previously [37]. The resulting ensemble of 20 structuresin 96-well plates with PS/20 medium. Supernatants were decanted,
and stimulation medium (PS/20, 0.5% BSA, and 25 nM IGF-1) was converged to a single global fold (mean rmsd from the mean struc-
ture of 0.31  0.06 A˚ and 1.18  0.15 A˚ for backbone or all heavyadded. After 15 min at 37	C, the stimulation medium was removed,
and cells were lysed by the addition of lysis buffer (50 mM HEPES, atoms, respectively, of residues 3–15). The structures agreed with
the input data very well (no distance restraint violations greater than150 mM NaCl, 0.5% Triton X-100, 1.0 mM 4-[2-aminoethyl]benzene-
sulfonyl fluoride hydrochloride, 30 kIU/ml aprotinin, 50 uM leupeptin, 0.07 A˚ and no dihedral angle violations greater than 1.0	), and had
good covalent geometry as judged by the program PROCHECK [25].and 2.0 mM sodium orthovanadate).
The lysates were transferred to immunosorbant plates that had
been coated overnight with 100 l anti-hIR antibody (2 g/ml) and Supplementary Material
blocked with BSA. After 2 hr incubation to allow for capture of NMR resonance assignments for peptides IGF-F1-1 and IGF-1-par-
solubilized hIR from the lysates, the plates were washed and anti- ent are available in Supplementary Tables 1 and 2. Supplementary
phosphotyrosine antibody 4G10 (Upstate Biologicals Inc.) was Table 2 contains details of the input restraints used to calculate the
added to detect activated hIR. After 2 hr incubation, the plates were structure of IGF-F1-1 and quality and precision statistics for the
developed with streptavidin conjugated to HRP and TMB substrate resulting ensemble.
as described above.
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